Tlr9 Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DVAX | C | Dynavax Technologies Corporation | 0.94 | |
ABUS | D | Arbutus Biopharma Corporation | 2.62 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 1.93 | |
BBP | C | BioShares Biotechnology Products Fund | 1.53 | |
SIXS | B | 6 Meridian Small Cap Equity ETF | 1.31 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.0 | |
PSCH | C | PowerShares S&P SmallCap Health Care Portfolio | 0.95 |
Compare ETFs
- Tlr9
Toll-like receptor 9 is a protein that in humans is encoded by the TLR9 gene. TLR9 has also been designated as CD289 (cluster of differentiation 289). It is a member of the toll-like receptor (TLR) family. TLR9 is an important receptor expressed in immune system cells including dendritic cells, macrophages, natural killer cells, and other antigen presenting cells. TLR9 preferentially binds DNA present in bacteria and viruses, and triggers signaling cascades that lead to a pro-inflammatory cytokine response. Cancer, infection, and tissue damage can all modulate TLR9 expression and activation. TLR9 is also an important factor in autoimmune diseases, and there is active research into synthetic TLR9 agonists and antagonists that help regulate autoimmune inflammation.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles